• Info
  • Insider Ownership

Insider Trading & Ownership of Sean P. Nolan

Location
Brisbane, CA
Summary
The estimated net worth of Sean P. Nolan is at least $23,725,180 dollars as of 27 Jan 2026. Sean P. Nolan is the Chief Executive Officer, Director of Taysha Gene Therapies, Inc. and owns shares of Taysha Gene Therapies, Inc. (TSHA) stock worth about $21.85M. Sean P. Nolan is the Director of Ventas, Inc. and owns shares of Ventas, Inc. (VTR) stock worth about $1.87M.
Signature
/s/ Kamran Alam, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Sean P. Nolan and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Sean P. Nolan has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $23,725,180.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Taysha Gene Therapies, Inc. ($21,852,561).
  • Past-year value change for that position: -$840,196.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Sean P. Nolan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TSHA Taysha Gene Therapies, Inc. Chief Executive Officer, Director $21,852,561 -$840,196 -3.7% 23 Jan 2026
VTR Ventas, Inc. Director $1,872,619 31 Dec 2025
DNAB Social Capital Suvretta Holdings Corp. II Director 24 Sep 2021

Insider Transactions Reported by Sean P. Nolan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.